The Patent Trial and Appeal Board of the U.S. Patent and Trademark Office has decided to institute a trial in a patent dispute involving BeiGene (NASDAQ:BGNE) and AbbVie (NYSE:ABBV) unit Pharmacyclics...
Source LinkThe Patent Trial and Appeal Board of the U.S. Patent and Trademark Office has decided to institute a trial in a patent dispute involving BeiGene (NASDAQ:BGNE) and AbbVie (NYSE:ABBV) unit Pharmacyclics...
Source Link
Comments